Tovuti hii inatekeleza vipengele vya msingi kwa sasa na bado haiko tayari kwa matumizi ya wagonjwa.
Tovuti hii inatekeleza vipengele vya msingi kwa sasa na bado haiko tayari kwa matumizi ya wagonjwa.
Biotech company focusing on next-generation vaccines
Founded in 1987, Novavax develops next-generation protein-based vaccines using recombinant nanoparticle technology, including candidates for COVID-19, influenza, and RSV.
Hakuna data
Hakuna vitu vya FAQ.